Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.3348
H.R.3348: Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced July 20, 2017
- Latest Major Action July 20, 2017
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
5 (2 Democrats, 3 Republicans)
Bill Version
- Introduced in House - July 20, 2017
Bill Summary
Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act This bill amends the Federal Food, Drug, and Cosmetic Act to include Middle East respiratory syndrome under the priority review voucher program for tropical diseases, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or...
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| July 20, 2017 |
Referred to the House Committee on Energy and Commerce.
|
| July 20, 2017 |
Introduced in the House by Scott Peters (D-Calif.) |